RxDoctor Payments Data

Charles Kirkham, MD

Obstetrics & Gynecology · Corpus Christi, TXNPI 1316911191

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $45,337 of the $54,405 with a category attached, or 83.3%. 23 manufacturers reported payments, led by Myovant Sciences Inc. at 51.9% of the total. Among obstetrics & gynecology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$54,405in general payments, 2019–2025

Across 181 payments — averaging $300.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Myovant Sciences Inc.$28K
  • Biogen$12K
  • Sumitomo Pharma America, Inc.$8K
  • Duchesnay USA Incorporated$5K
  • AbbVie$448
  • Astellas Pharma US Inc$254
  • plus $977 from 17 others
$298,822in research payments, 2019–2025

Across 62 payments — averaging $4819.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Abbott$240K
  • GSK$27K
  • Ferring International Pharmascience Center US$23K
  • Exeltis, USA Inc.$9K
  • Sun Pharmaceutical Industries Inc.$1K

What the payments were for

  • Consulting fees$2,0804%
  • Speaking & faculty fees$45,33783%
  • Travel & lodging$3,2856%
  • Food & beverage$3,5667%
  • Education$1360%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,405 in reported general payments places this provider in the 95th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas

Medicare billing

Part B allowed, 2024
$17,911
Medicare patients
98
Services billed
366

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
PremarinEstrogens, Conjugated17$8,287
Estradiol78$3,640
ProgesteroneProgesterone, Micronized32$1,848
Raloxifene Hcl38$1,609
Medroxyprogesterone Acetate13$575
Clobetasol Propionate21$361
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip17$316
Fluconazole18$110

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Corpus Christi

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →